Precision Cancer Care Without Borders: United Theranostics Brings Life-Saving Treatment Home Through a bold 50-state expansion plan, United Theranostics is eliminating travel barriers for cancer patients and fueling local economies with high-skill medical jobs

Every year, thousands of cancer patients forgo life-extending therapies because they live too far from treatment centers. United Theranostics is on a mission to change that, permanently.

United Theranostics is fundamentally reshaping personalized cancer care through a decentralized model. This innovative approach aims to eliminate the arduous travel often associated with life-saving therapies, instead delivering advanced precision oncology directly into local communities. This strategy is driven by the understanding that convenient access to care can significantly improve treatment adherence and patient well-being, especially for complex therapies. By mitigating logistical burdens, patients can dedicate their energy to recovery, transforming the often-daunting medical journey into a more manageable path.

"Our business model is built on the conviction that decentralized access to cutting-edge
theranostics will revolutionize cancer care ensuring every patient receives precision
treatment close to home, transforming both outcomes and lives." - Robert Cherney, CEO

At the core of this transformation is the integration of cutting-edge diagnostic imaging with targeted therapies. A notable example is the groundbreaking Pluvicto, an FDA-approved radioligand therapy for metastatic castration-resistant prostate cancer (mCRPC). For men battling mCRPC, Pluvicto represents a significant advancement, and United Theranostics' mission is to make such innovative treatments accessible to every patient, regardless of their geographic location. This commitment extends beyond advanced medicine, aiming to empower patients with precise, effective treatment while restoring the comfort and support of their home environment, thereby establishing a strategic healthcare model that prioritizes both clinical excellence and human dignity.

"For men facing prostate cancer, we are fundamentally reshaping how radiological care is delivered by seamlessly integrating advanced diagnostics with targeted therapies like Pluvicto, bringing personalized hope and life-extending treatment directly into their communities," - Dr. Munir Ghesani MD, Chief Medical Officer.

United Theranostics is implementing an ambitious plan to establish clinics across all 50 states within the next seven years, a strategic move designed to ensure advanced, life-extending cancer treatments are available in local communities. This decentralized model not only expands access to FDA-approved radiotherapeutics but also accelerates the adoption of upcoming agents like Ac-225 PSMA and FAP-targeted therapies. The establishment of these facilities is expected to create high-skill jobs in radiopharmaceutical production and molecular imaging within local economies, while also fostering educational development through STEM programs and CME events for healthcare professionals.

This decentralized approach offers significant advantages for business-minded patients and healthcare organizations:

• Accessibility: By bringing state-of-the-art theranostics facilities directly to local communities, United Theranostics provides unparalleled convenience for patients, reducing travel and logistical challenges during treatment.
• Economic Impact: The establishment of these facilities creates high-skill jobs in radiopharmaceutical production and molecular imaging within local economies.
• Educational Development: United Theranostics supports STEM education programs in local schools and offers CME events and training for referring oncologists and technologists, fostering a knowledgeable workforce and advancing regional medical capabilities.
• Collaborative Care: The company emphasizes streamlined referral pathways and co-treatment plans with existing medical, radiation, and surgical oncologists, ensuring continuity of care. This collaborative model aims to enhance precision in patient care without adding complexity.

Visit www.UnitedTheranostics.com to learn more